Reglan will soon get a boxed warning of the risks of long term and high dose use, as recently required by the FDA. Reglan is one of a group of drugs containing metoclopramide, which is used to treat gastrointestinal disorders. According to the FDA, except for rare cases, patients should avoid chronic use of these drugs such as Reglan. There is a link between chronic use of metoclopramide and tardive dyskinesia, which involves involuntary and repetitive body movements, such as grimacing, tongue protrusion, rapid eye movements and impaired movement of fingers. This risk continues after the drug is stopped, and the symptoms are rarely reversible. The greatest risk is for the elderly, especially older women and people who have used the drug for a long time. Reglan comes in various formulations, including Reglan Tablets and Reglan Injection.
If you or someone you know has developed tardive dyskinesia after using Reglan, contact Sheller, P.C. Sheller has a long history of aggressive and passionate representation of individuals and classes of individuals with a wide range of legal claims, including personal injury, product liability and medical malpractice. Moreover, a team of Sheller attorneys is dedicated to obtaining compensation for people injured by defective drugs, such as Reglan.
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.